Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00161473 · ClinicalTrials.gov registry record · NA
Alzheimer's in Long-Term Care--Treatment for Agitation
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00161473 is a NA study that has completed, run by University of Washington. The registered enrollment target is 24 participants.
The verdict
NCT00161473, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a medication called prazosin is useful in the treatment of agitation and aggression in persons with Alzheimer's disease (AD) and other types of dementia in late life.
Interventions
- DRUG prazosin
- DRUG placebo (inert substance)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2001-01 |
| Est. Completion | 2009-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00161473
The ClinicalTrials.gov registry entry for NCT00161473 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which prazosin is the first listed.
NCT00161473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00161473 about?
NCT00161473 is a clinical study titled "Alzheimer's in Long-Term Care--Treatment for Agitation". The purpose of this study is to see if a medication called prazosin is useful in the treatment of agitation and aggression in persons with Alzheimer's disease (AD) and other types of dementia in late life.
What is the current status of trial NCT00161473?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2001-01. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00161473?
The interventions under investigation include: prazosin (DRUG), placebo (inert substance) (DRUG).
Who is sponsoring clinical trial NCT00161473?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.